Helix BioPharma Corp.

C$0.90As of Sun 8 Nov 2026, 12:00 UTC
TSX:HBPHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (19.07%)
Div yield —
ROE (22.51%)
Biotechnology
Beta (5Y) (0.12)
PE TTM —
TSR TTM (55.00%)
Mkt cap C$68.74M
ROIC (13.27%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.07
18.81%
(46.11%)
Hold 7|2|4|0|12
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.01
0.01
0.01
0.01
8.30%
20.21%
12.90%
24.69%
Revenue$M
4.829
5.026
5.019
4.989
7.96%
7.70%
3.87%
2.76%
Peers (US$48.66M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.948
(1.195)
(1.075)
EBIT/Intx
0.405
0.183
0.172
Own earn%
(1.54)
31.48
71.82
Sh yield%
30.88
36.87
33.78
Owners
Insiders/Inst%
8.10
43.75
Short interest%
0.53
SBC / revenue%
5.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
27–33
$1 testx
0.0
Incr. ROIC%
2